FDA Drug Application (076238) for BALZIVA-28 by BARR

Back to FDA Applications sponsored by BARR

Application Number076238
Product Number001
FormTABLET;ORAL-28
Dosage0.035MG;0.4MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameBALZIVA-28
Active IngredientETHINYL ESTRADIOL; NORETHINDRONE

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient NORETHINDRONE82


Back to FDA Applications sponsored by BARR